Benzinga | Jul 14, 2021 08:14AM EDT

Argus Research Upgrades United Therapeutics to Buy, Announces $205 Price Target

Argus Research analyst Jasper Hellweg upgrades United Therapeutics (NASDAQ:UTHR) from Hold to Buy and announces $205 price target.